論文

査読有り 国際誌
2021年11月1日

Detecting Adverse Drug Events Through the Chronological Relationship Between the Medication Period and the Presence of Adverse Reactions From Electronic Medical Record Systems: Observational Study

JMIR Medical Informatics
  • Kei Teramoto
  • ,
  • Toshihiro Takeda
  • ,
  • Naoki Mihara
  • ,
  • Yoshie Shimai
  • ,
  • Shirou Manabe
  • ,
  • Shigeki Kuwata
  • ,
  • Hiroshi Kondoh
  • ,
  • Yasushi Matsumura

9
11
開始ページ
e28763
終了ページ
e28763
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.2196/28763
出版者・発行元
JMIR Publications Inc.

Background

Medicines may cause various adverse reactions. An enormous amount of money and effort is spent investigating adverse drug events (ADEs) in clinical trials and postmarketing surveillance. Real-world data from multiple electronic medical records (EMRs) can make it easy to understand the ADEs that occur in actual patients.

Objective

In this study, we generated a patient medication history database from physician orders recorded in EMRs, which allowed the period of medication to be clearly identified.

Methods

We developed a method for detecting ADEs based on the chronological relationship between the presence of an adverse event and the medication period. To verify our method, we detected ADEs with alanine aminotransferase elevation in patients receiving aspirin, clopidogrel, and ticlopidine. The accuracy of the detection was evaluated with a chart review and by comparison with the Roussel Uclaf Causality Assessment Method (RUCAM), which is a standard method for detecting drug-induced liver injury.

Results

The calculated rates of ADE with ALT elevation in patients receiving aspirin, clopidogrel, and ticlopidine were 3.33% (868/26,059 patients), 3.70% (188/5076 patients), and 5.69% (226/3974 patients), respectively, which were in line with the rates of previous reports. We reviewed the medical records of the patients in whom ADEs were detected. Our method accurately predicted ADEs in 90% (27/30patients) treated with aspirin, 100% (9/9 patients) treated with clopidogrel, and 100% (4/4 patients) treated with ticlopidine. Only 3 ADEs that were detected by the RUCAM were not detected by our method.

Conclusions

These findings demonstrate that the present method is effective for detecting ADEs based on EMR data.

リンク情報
DOI
https://doi.org/10.2196/28763
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/33993103
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593795
ID情報
  • DOI : 10.2196/28763
  • eISSN : 2291-9694
  • PubMed ID : 33993103
  • PubMed Central 記事ID : PMC8593795

エクスポート
BibTeX RIS